These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26283448)

  • 21. Erythrokeratoderma variabilis responding to low-dose isotretinoin.
    Singh N; Thappa DM
    Pediatr Dermatol; 2010; 27(1):111-3. PubMed ID: 20199434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequencing identifies novel compound heterozygous mutations in GJB3 gene that cause erythrokeratodermia variabilis et progressiva.
    Deng Y; Wang H; Mou Y; Zeng Q; Xiong X
    Australas J Dermatol; 2019 Feb; 60(1):e87-e89. PubMed ID: 29992552
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammatory Linear Verrucous Epidermal Nevus with a Postzygotic GJA1 Mutation Is a Mosaic Erythrokeratodermia Variabilis et Progressiva.
    Umegaki-Arao N; Sasaki T; Fujita H; Aoki S; Kameyama K; Amagai M; Seishima M; Kubo A
    J Invest Dermatol; 2017 Apr; 137(4):967-970. PubMed ID: 27890787
    [No Abstract]   [Full Text] [Related]  

  • 24. Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4.
    Zhang X; Xu P; Lu J; Ding Y; Gu J; Shi Y
    Exp Dermatol; 2022 Apr; 31(4):594-599. PubMed ID: 34717022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrokeratodermia variabilis with hypertrichosis on the lesions.
    Wu JP; Ge HS; Yang C
    Chin Med J (Engl); 2020 Feb; 133(4):501-502. PubMed ID: 31977560
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism.
    Tang C; Chen X; Chi J; Yang D; Liu S; Liu M; Pan Q; Fan J; Wang D; Zhang Z
    Hum Mol Genet; 2015 Nov; 24(21):6054-65. PubMed ID: 26251042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive symmetrical erythrokeratodermia -- case report.
    Guaraldi Bde M; Jaime TJ; Guaraldi Rde M; Melo DF; Nogueira OM; Rodrigues N
    An Bras Dermatol; 2013; 88(1):109-12. PubMed ID: 23539014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both low-dose arotinoid ethylester and acitretin are effective in the treatment of familial erythrokeratodermia variabilis.
    Zhang L; Hong Y; Zheng S; Huo W; Qi R; Geng L; Chen HD; Gao XH
    Dermatol Ther; 2014; 27(4):240-3. PubMed ID: 24754264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
    de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS
    Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial erythrokeratodermia variabilis with pustular lesions: a new variant?
    Zhang L; Huo W; Gao XH; Ma L; Xiu Y; Zheng S; Hong Y; Chen HD
    Acta Derm Venereol; 2010 May; 90(3):274-8. PubMed ID: 20526545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy for breast cancer and erythrokeratodermia variabilis.
    Pernin V; Kirova Y; Campana F
    Cancer Radiother; 2014 Dec; 18(8):767-9. PubMed ID: 25306447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A heterozygous mutation in GJA1 gene in Chinese family with serious erythrokeratodermia variabilis et progressive.
    Guo BR; Cai HB; Zong WK; Li CS; Liu LZ; Qiao S; Zhu QM; Li M
    Chin Med J (Engl); 2019 Jan; 132(1):86-88. PubMed ID: 30628963
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythrokeratodermia variabilis].
    Bilan P; Levy A; Sin C; Marchal A; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2013 Feb; 140(2):129-33. PubMed ID: 23395496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Progressive symmetric erythrokeratodermia: Activating mutations of TRPM4].
    Dereure O
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):600-601. PubMed ID: 31358308
    [No Abstract]   [Full Text] [Related]  

  • 35. From progressive symmetric erythrokeratoderma to erythrokeratoderma variabilis progressiva.
    Hirano SA; Harvey VM
    J Am Acad Dermatol; 2011 May; 64(5):e81-2. PubMed ID: 21496691
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations.
    Richard G; Brown N; Rouan F; Van der Schroeff JG; Bijlsma E; Eichenfield LF; Sybert VP; Greer KE; Hogan P; Campanelli C; Compton JG; Bale SJ; DiGiovanna JJ; Uitto J
    J Invest Dermatol; 2003 Apr; 120(4):601-9. PubMed ID: 12648223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Symptomatology & treatment of a late form of erythrokeratodermia figurata variabilis].
    FLECK F
    Dermatol Wochenschr; 1957 Apr; 135(16):393-401. PubMed ID: 13447448
    [No Abstract]   [Full Text] [Related]  

  • 38. Symmetrical erythematosquamous figurate plaques in a young man.
    Chen WH; Chiang CP; Chen JF; Wang WM; Wu BY
    Clin Exp Dermatol; 2014 Oct; 39(7):850-1. PubMed ID: 25196651
    [No Abstract]   [Full Text] [Related]  

  • 39. Progressive symmetric erythrokeratodermia with spinocerebellar ataxia due to ELOVL4 mutation in a Chinese family.
    Wang Z; Lin Z; Wang H
    Indian J Dermatol Venereol Leprol; 2021; 88(1):132. PubMed ID: 34623043
    [No Abstract]   [Full Text] [Related]  

  • 40. Progressive symmetric erythrokeratoderma: report of an Indian family.
    Gupta LK; Saini P; Khare AK; Mittal A
    Int J Dermatol; 2014 May; 53(5):e317-9. PubMed ID: 24601895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.